Switzerland, Intermediary

Changechevron_right
highlight_off

Thank you for your registration

You will shortly receive an email with your unique link to our preference center.

Wellington Alternative Investments

...

Contact us

menu
search
Skip to main content

Search to find the correct information:
search
Search

Biotech

Showing of Insights Posts
nilesh-kumar1
nilesh-kumar1
Video
3 min
Innovation Venture capital Biotech Private Investing Program Private investing Video Private Biotech
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech innovation versus hype

Nilesh Kumar discusses the next generation of biotech disruptors in obesity, autoimmunity, and oncology, focusing on drugs that solve real-world unmet medical needs.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
event
3 min
Video
2026-06-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1349253411
1349253411
Article
5 min
Private Biotech Liquid alternatives & hedge funds Biotech Health care Venture capital Article Innovation Private investments Private Investing Program Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private biotech: Immunology and inflammation’s third wave

Our experts discuss how I&I is building on industry progress to offer new treatment solutions and interesting opportunities for private biotech investors. 

Continue reading

Multiple authors

event
5 min
Article
2025-12-01
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
97970762
97970762
Article
8 min
Small-cap Global Industry Research Biotech Institutional Program Discover Large-cap Thematic solutions Article Equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Strong fundamentals, attractive valuations: Why the time may be right for active biotech investing

From solid fundamentals to supportive macro conditions, learn why our biotech experts believe the industry may be ready to run.

Continue reading

By

Wen Shi
Wen Shi, PhD, CFA
Mark Sevecka
Mark Sevecka, PhD
event
8 min
Article
2025-10-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
2032712798
2032712798
Article
4 min
Private investing Private Biotech Biotech Venture capital Article Private Investing Program Private companies Private equity
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech IPOs in 2025: Quantity, quality, and best practices

We explore today's biotech IPO market, highlighting recent market trends, key characteristics for successful biotech IPOs, and best practices to sustain momentum as a public biotechnology company.

Continue reading

By

Nilesh Kumar
Nilesh Kumar, PhD
William Craig
William Craig
event
4 min
Article
2025-08-31
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1441707651
1441707651
Video
Biotech Venture capital Private equity Private investments Private portfolio companies Late stage Liquid alternatives & hedge funds Video
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Private investing portfolio company interview with RayzeBio CEO Ken Song

Dr. Ken Song, President and CEO of RayzeBio, discusses the company’s innovative approach to radiopharmaceuticals and highlights how Wellington’s public and private investment expertise is distinctive in the health care space.

Continue reading
event
Video
2024-09-30
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
1410189307
1410189307
Article
Biotech Private equity Private companies Private investments Innovation Article
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.

Biotech for the next decade: Private market innovations

We explore our latest research in private biotech innovation across immunomodulatory therapies, precision oncology, antibody drug conjugates, radiopharmaceuticals, genetic medicines, and a range of other novel treatment modalities.

Continue reading

Multiple authors

event
Article
2024-07-14
Archived info
Archived pieces remain available on the site. Please consider the publish date while reading these older pieces.
6 LOAD {count} MORE

URL References

Related Insights

© Copyright 2025 Wellington Management Europe GmbH. All rights reserved. WELLINGTON MANAGEMENT FUNDS ® is a registered service mark of Wellington Group Holdings LLP.
Wellington Management Switzerland GmbH. Registered at the commercial register of the canton of Zurich with number CH-020.4.050.857-7
For professional investors and intermediaries only. This content is not suitable for a retail audience.

In Switzerland, the Fund offering documents can be obtained from the local Representative and Paying Agent, BNP Paribas Securities Services, Selnaustrasse 16, 8002 Zurich, Switzerland. The Prospectuses are available in English, French and Swiss French.

View More

Enjoying this content?

Get similar insights delivered straight to your inbox. Simply choose what you’re interested in and we’ll bring you our best research and market perspectives.

View More
highlight_off

Thank you for joining our email preference center.

You’ll soon receive an email with a link to access and update your preferences.

Sorry, not interested

View More